Meta-analysis of randomized trials comparing thiopurines in childhood acute lymphoblastic leukaemia
Mercaptopurine has been used in continuing treatment for childhood acute lymphoblastic leukaemia since the mid 1950s. Recent advances in the understanding of thiopurine pharmacology indicated thioguanine might be more effective than mercaptopurine. The US and UK cooperative groups began randomized t...
Main Authors: | Escherich, Gabriele M, Richards, Sue, Stork, Linda C, Vora, Ajay J |
---|---|
Format: | Online |
Language: | English |
Published: |
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112460/ |
Similar Items
-
Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics
by: Lennard, Lynne, et al.
Published: (2014) -
Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003
by: Lennard, Lynne, et al.
Published: (2015) -
Thiopurine methyltransferase genotyping in Palestinian childhood acute lymphoblastic leukemia patients
by: Ayesh, Basim Mohammad, et al.
Published: (2013) -
Long survival in childhood lymphoblastic leukaemia.
by: Chessells, J. M., et al.
Published: (1987) -
Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia
by: Linga, Vijay Gandhi, et al.
Published: (2014)